Treating locally advanced or metastatic urothelial cancer with Anti-191p4d12 antibody drug conjugates in combination with pembrolizumab
PH12026550745A1Pending Publication Date: 2026-06-29AGENSYS INC +2
Patent Information
- Authority / Receiving Office
- PH · PH
- Patent Type
- Applications
- Current Assignee / Owner
- AGENSYS INC
- Filing Date
- 2026-03-19
- Publication Date
- 2026-06-29
Need to check novelty before this filing date? Find Prior Art
No text content released.